Skip Nav Destination
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
Issue Archive
July 5 2012
Table of Contents
Inside Blood
Blood Work
Plenary Paper
PLENARY PAPER
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Clinical Trials & Observations
Michele Cavo,Lucia Pantani,Maria Teresa Petrucci,Francesca Patriarca,Elena Zamagni,Daniela Donnarumma,Claudia Crippa,Mario Boccadoro,Giulia Perrone,Antonietta Falcone,Chiara Nozzoli,Renato Zambello,Luciano Masini,Anna Furlan,Annamaria Brioli,Daniele Derudas,Stelvio Ballanti,Maria Laura Dessanti,Valerio De Stefano,Angelo Michele Carella,Magda Marcatti,Andrea Nozza,Felicetto Ferrara,Vincenzo Callea,Catello Califano,Annalisa Pezzi,Anna Baraldi,Mariella Grasso,Pellegrino Musto,Antonio Palumbo,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network,for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network
Perspectives
Review Article
Hematopoiesis and Stem Cells
Immunobiology
SAP expression in invariant NKT cells is required for cognate help to support B-cell responses
Cynthia Detre,Marton Keszei,Natividad Garrido-Mesa,Katalin Kis-Toth,Wilson Castro,Amma F. Agyemang,Natacha Veerapen,Gurdyal S. Besra,Michael C. Carroll,George C. Tsokos,Ninghai Wang,Elizabeth A. Leadbetter,Cox Terhorst
Lymphoid Neoplasia
Myeloid Neoplasia
Survivin is highly expressed in CD34+38− leukemic stem/progenitor cells and predicts poor clinical outcomes in AML
Bing Z. Carter,Yihua Qiu,Xuelin Huang,Lixia Diao,Nianxiang Zhang,Kevin R. Coombes,Duncan H. Mak,Marina Konopleva,Jorge Cortes,Hagop M. Kantarjian,Gordon B. Mills,Michael Andreeff,Steven M. Kornblau
Phagocytes, Granulocytes, and Myelopoiesis
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4
Qian Liu,Haoqian Chen,Teresa Ojode,Xiangxi Gao,Sandra Anaya-O'Brien,Nicholas A. Turner,Jean Ulrick,Rosamma DeCastro,Corin Kelly,Adela R. Cardones,Stuart H. Gold,Eugene I. Hwang,Daniel S. Wechsler,Harry L. Malech,Philip M. Murphy,David H. McDermott
Platelets and Thrombopoiesis
Thrombosis and Hemostasis
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
Clinical Trials & Observations
Francesco Baudo,Peter Collins,Angela Huth-Kühne,Hervé Lévesque,Pascual Marco,László Nemes,Fabio Pellegrini,Lilian Tengborn,Paul Knoebl,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors,on behalf of the EACH2 registry contributors
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Clinical Trials & Observations
Peter Collins,Francesco Baudo,Paul Knoebl,Hervé Lévesque,László Nemes,Fabio Pellegrini,Pascual Marco,Lilian Tengborn,Angela Huth-Kühne,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators,on behalf of the EACH2 registry collaborators
Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia
Rafael H. Jácomo,Barbara A. Santana-Lemos,Ana Silvia G. Lima,Patricia A. Assis,Ana Paula A. Lange,Lorena L. Figueiredo-Pontes,Luciana O. Oliveira,Sarah C. Bassi,Mariana T. L. Benício,Márcia S. Baggio,Aglair B. Garcia,Roberto P. Falcão,Eduardo M. Rego
Transplantation
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
Clinical Trials & Observations
Anita D'Souza,Martha Lacy,Morie Gertz,Shaji Kumar,Francis Buadi,Suzanne Hayman,David Dingli,Steven Zeldenrust,Robert Kyle,Stephen Ansell,David Inwards,Patrick Johnston,Ivana Micallef,Luis Porrata,Mark Litzow,Dennis Gastineau,William Hogan,Angela Dispenzieri
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins
Yoshihiro Eriguchi,Shuichiro Takashima,Hideyo Oka,Sonoko Shimoji,Kiminori Nakamura,Hidetaka Uryu,Shinji Shimoda,Hiromi Iwasaki,Nobuyuki Shimono,Tokiyoshi Ayabe,Koichi Akashi,Takanori Teshima
Vascular Biology
-
Cover Image
Cover Image
![issue cover]()
Computer simulation of a plume of ADP (top) and thromboxane (middle) released from platelets depositing on collagen under hemodynamic conditions (flow streamlines and shear rate indicated in bottom panel). The intracellular calcium state of the platelets ranges from resting (black) to full activation (white) and is based upon a personalized model obtained for a single blood donor. See the article by Flamm et al on page 190.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
